Drawing for MODERNA

USPTO serial 88903508

MODERNA

Reviewed by CopyMark Law Group

Reg. 7279624Status 700Registered
Filing date
Status date
Registration date
Jan 16, 2024
Examiner
RICHARDS, LESLIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MODERNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Francis Ward

John Francis Ward Moderna325 Binney StreetCambridge, MA 02142United States

Goods and services

ClassDescriptionStatusFirst use
001biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders and infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory useACTIVEMay 30, 2013
005medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and infectious disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagentsACTIVEMay 30, 2013
042scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acidsACTIVEDec 6, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 31, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 31, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 31, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 31, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 22, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 12, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 6, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 1, 2023IUAFUSE AMENDMENT FILED—
Nov 1, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 30, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 30, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 30, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 10, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 25, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 24, 2023EX5GSOU EXTENSION 5 GRANTED—
Apr 24, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 18, 2023EXT5SOU EXTENSION 5 FILED—
Apr 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 30, 2022EX4GSOU EXTENSION 4 GRANTED—
Oct 30, 2022EXT4SOU EXTENSION 4 FILED—
Oct 30, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2022EX3GSOU EXTENSION 3 GRANTED—
May 3, 2022EXT3SOU EXTENSION 3 FILED—
May 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 26, 2021EX2GSOU EXTENSION 2 GRANTED—
Oct 26, 2021EXT2SOU EXTENSION 2 FILED—
Oct 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 26, 2021EX1GSOU EXTENSION 1 GRANTED—
Apr 26, 2021EXT1SOU EXTENSION 1 FILED—
Apr 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 8, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 31, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 31, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 31, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 31, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 31, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 31, 2020DOCKASSIGNED TO EXAMINER—
May 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance